mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.3 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.3 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.3 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.3 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.3 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.3 |